Cytomedix Inc (NASDAQOTCBB:CMXI)

CAPS Rating: 1 out of 5

A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.

Recs

0
Player Avatar pchop123 (76.62) Submitted: 8/3/2012 10:28:57 AM : Outperform Start Price: $1.59 CMXI Score: -15.95

Looking for partnership posibility near term and the price is right now after a substantial downward correction

Featured Broker Partners


Advertisement